Standard Probiotic Prescription for Adults
There is no single "standard" probiotic to routinely prescribe for adults without a specific indication—probiotics should only be used in targeted clinical scenarios, not as general supplements. 1
Evidence-Based Approach to Probiotic Selection
The 2020 AGA Clinical Practice Guidelines provide the most authoritative framework for probiotic use 1. The key principle is that probiotic efficacy is both strain-specific and disease-specific—you cannot prescribe "a probiotic" generically 2.
When to Prescribe Probiotics in Adults
For antibiotic-associated diarrhea prevention (the most common appropriate indication):
The AGA conditionally recommends specific formulations for adults on antibiotics 1:
- Saccharomyces boulardii (most extensively studied, evidence across all patient groups) 3
- 2-strain combination: L. acidophilus CL1285 + L. casei LBC80R
- 3-strain combination: L. acidophilus + L. delbrueckii subsp bulgaricus + B. bifidum
- 4-strain combination: L. acidophilus + L. delbrueckii subsp bulgaricus + B. bifidum + S. salivarius subsp thermophilus
Important caveat: This is a conditional recommendation with low-quality evidence 1. Patients with severe illness, high cost concerns, or low baseline C. difficile risk (especially outpatients) may reasonably decline probiotics.
When NOT to Prescribe Probiotics
The AGA explicitly recommends probiotics only in clinical trial contexts for 1:
- Crohn's disease
- Ulcerative colitis
- Irritable bowel syndrome
- C. difficile infection treatment
This means do not prescribe probiotics for these conditions in routine practice.
Clinical Decision Algorithm
Identify the specific indication: Is the patient starting antibiotics with high C. difficile risk (hospitalized, elderly, multiple antibiotics)?
If yes to antibiotic prophylaxis: Choose S. boulardii as first-line (strongest evidence base) 3, 4 or one of the specific multi-strain combinations listed above
If no clear indication: Do not prescribe—explain that probiotics lack evidence for general wellness or most GI conditions 1
Verify the exact strain: The product label must match the studied strain designation (e.g., S. boulardii CNCM I-745, not just "Saccharomyces") 2
Critical Pitfalls to Avoid
- Do not prescribe generic "probiotics": Different strains of the same species have different effects 3, 2
- Do not assume all Lactobacillus or Bifidobacterium products are equivalent: Only specific strain combinations have evidence 1
- Do not use in severely immunocompromised patients: Safety data are limited 1
- Do not prescribe for acute infectious gastroenteritis in adults: The AGA suggests against this in children, and evidence in adults is insufficient 1
Quality and Dosing Considerations
When prescribing, specify:
- Exact strain designation (not just genus/species)
- Dose: Most studied formulations use ≥5 × 10⁹ CFU daily 5, though this varies by product
- Duration: Typically throughout antibiotic course plus 1-2 weeks after
- Reputable manufacturer: Product quality and viability vary significantly 1
The Bottom Line
Without a specific clinical indication (primarily antibiotic-associated diarrhea prevention in high-risk patients), do not prescribe probiotics. When indicated, prescribe S. boulardii or one of the four specific multi-strain combinations with documented evidence, ensuring the exact strain matches published studies. The evidence base remains limited (low quality), and most GI conditions lack sufficient data to support probiotic use outside research settings 1.